#fenebrutinib — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #fenebrutinib, aggregated by home.social.
-
https://www.europesays.com/ch/58992/ Genentech fenebrutinib cuts relapsing MS relapses 51%-59% #BrainLesions #BTKInhibitor #fenebrutinib #Genentech #PhaseIIITrial #RelapseReduction #RelapsingMultipleSclerosis #RHHBY #Roche
-
https://www.europesays.com/ch/53352/ Roche’s fenebrutinib cuts relapses in MS amid safety concerns #fenebrutinib #MultipleSclerosis #PhaseIII #RelapsingMultipleSclerosis #Roche
-
https://www.europesays.com/ch/53240/ Roche fenebrutinib cuts RMS relapses 51%-59% #AnnualisedRelapseRate #BrainLesions #BTKInhibitor #fenebrutinib #PhaseIII #RelapsingMultipleSclerosis #RHHBY #Roche
-
https://www.europesays.com/ch/53232/ #AAN26: Roche’s multiple sclerosis pill delays relapse, but liver toxicity could need monitoring #Aubagio #BTKInhibitors #fenebrutinib #LeviGarraway #Ocrevus #R&D #Roche
-
https://www.europesays.com/ch/31459/ Genentech fenebrutinib slashes MS relapses 51% #BTKInhibitor #fenebrutinib #Genentech #MultipleSclerosis #PhaseIII #PrimaryProgressiveMS #RelapseRate #RelapsingMS #RHHBY #Roche #teriflunomide
-
https://www.europesays.com/es/389934/ Fenebrutinib muestra resultados positivos frente a la progresión de la discapacidad en EMPP #beneficio #clínico #comparable #confirman #datos #Discapacidad #empp #ES #España #especialmente #Estudio #extremidades #fase #fenebrutinib #fentrepid #frente #funcion #Health #iii #inferioridad #muestra #no #ocrelizumab #perfil #positivos #presenta #progresión #resultados #roche #Salud #seguridad #sostenido #Spain #superiores #temprano
-
https://www.europesays.com/uk/753430/ Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News #BTKInhibitor #Fenebrutinib #FENtrepid #Health #Medication #MultipleSclerosis #Ocrevus #pharma #PPMS #R&D #Roche #Sanofi #Tolebrutinib #UK #UnitedKingdom